美股連升兩日,標普500指數史上首次收在5,500點以上,納斯達克指數突破18,000點到數市,雙雙創新高。聯邦儲備局主席鮑威爾表示,對抗通脹的行動「取得相當大的進展」,惟未有暗示減息路線圖;Tesla上季電動車出貨量好過預期,股價急漲一成。
(Bloomberg) -- Novo Nordisk A/S and Eli Lilly & Co. shares fell Tuesday after US President Joe Biden continued his push for cheaper medicines by demanding price cuts on their blockbuster weight-loss and diabetes drugs. Most Read from BloombergDemocrats Weigh Mid-July Vote to Formally Tap Biden as NomineePowerful Storm Beryl Aims at Jamaica After Grenada StrikeS&P 500 Closes Above 5,500 in Record-Breaking Run: Markets Wrap‘Upflation’ Is the New Retail Trend Driving Up Prices for US ConsumersTrump
Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.